To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 1
This profile is validated by 1 label.

Company

Medyria AG

Medyria AG_logo
14
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

Winterthur, Zürich, Switzerland

Send a message

English

Medyria AG

English

Medyria is a Swiss MedTech  start-up founded in 2013 by Dr.  Mauro Sette  offering innovative technologies to cardiologists that increase patient and physician safety whilst minimising procedural manipulations, reducing procedure time and potential complications and lowering total treatment costs.  The company is located in the Technopark Winterthur business centre in Switzerland and its facilities include: administration and quality office, production laboratory,...

See more

Medyria is a Swiss MedTech  start-up founded in 2013 by Dr.  Mauro Sette  offering innovative technologies to cardiologists that increase patient and physician safety whilst minimising procedural manipulations, reducing procedure time and potential complications and lowering total treatment costs.  The company is located in the Technopark Winterthur business centre in Switzerland and its facilities include: administration and quality office, production laboratory, R&D laboratory and store room. Medyria  has a lean and dynamic team of 6 people combining more than 50 years’ cumulative experience in biomedical and cardiac engineering, clinical research, project management, business development and marketing.Medyria carried out extensive market research with cardiac specialists and uncovered an unmet market need for real-time assessment of the anatomy and physiology of coronary and micro- vasculature of the heart, which their sensing technology could address.  PhysioCath is an all in one, plug & play device designed to be used during standard angiography procedures to provide cardiologists with real-time information about key coronary indexes. Medyria has a strong IP strategy and its technology is protected by 4 patent families secured in strategic markets: Europe, China, Japan, and US.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members
Access2EIC
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
2141 Members